Abstract
Platelets contribute to atherosclerosis in a number of ways. At sites of injury of arterial walls, they can promote smooth muscle cell proliferation by releasing growth factors1,2. Platelet-fibrin thrombi that form at injury sites on vessel walls or on advanced atherosclerotic lesions can be organized and contribute to vessel wall thickening3–6, and arterial thrombi composed of platelets and fibrin are responsible for clinical complications of atherosclerosis: thromboembolism and occlusive thrombosis7,8. Activated platelets in a thrombus can also release materials that cause vasospasm9.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ross, R. 1986. The pathogenesis of atherosclerosis - an update. New Engl. J. Med. 314: 488–500.
Moore, S. 1981. Injury mechanisms in atherogenesis. In: Moore, S., ed., Vascular injury and atherosclerosis. New York: Marcel Dekker, 131–148.
Duguid, J.B. 1946. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J. Pathol. Bacteriol. 58: 207–212.
Jorgensen, L., Rowsell, H.C., Hovig, T. and Mustard, J.F. 1967. Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am. J. Pathol. 51: 681–693.
Woolf, N. 1987. Thrombosis and atherosclerosis. In: Bloom, A.L. and Thomas, D.P., eds. Haemostasis and thrombosis. Second Edition. New York: Churchill Livingstone, 651–678.
Faxon, D.P., Sanborn, T.A., Weber, V.J., et al. 1984. Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 4: 189–195.
Davies, M.J. 1987. Thrombosis in acute myocardial infarction and sudden death. Cardiovasc. Clin. 18: 151–159.
Packham, M.A. and Mustard, J.F. 1986. The role of platelets in the development and complications of atherosclerosis. Semin. Hematol. 23: 8–26.
Willerson, J.T., Golino, P., Eidt, J., Campbell, W.B. and Buja, L.M. 1989. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 80: 198–205.
Kroll, M.H. and Schafer, A.I. 1989. Biochemical mechanisms of platelet activation. Blood 74: 1181–1195.
Siess, W. 1989. Molecular mechanisms of platelet activation. Phvsiol. Rev. 69: 58–178.
Mustard, J.F., Packham, M.A. and Kinlough-Rathbone, R.L. 1990. Platelets, blood flow, and the vessel wall. Circulation 81 (Suppl I): I-24-I-27.
Holmsen, H. 1989. Physiological functions of platelets. Ann. Med. 21: 23–30.
Baumgartner, H.R. and Muggli, R. 1976. Adhesion and aggregation: Morphological demonstration and quantitation in vivo and in vitro. In: Gordon, J.L., ed., Platelets in biology and pathology. Oxford: Elsevier/North Holland, 23–60.
Packham, M.A. and Mustard, J.F. 1984. Platelet adhesion. In: Spaet, T.H., ed. Progress in hemostasis and thrombosis. Vol. 7. New York: Grune & Stratton, 211–288.
Packham, M.A. 1988. The behaviour of platelets at foreign surfaces. Proc. Soc. Exp. Biol. Med. 189: 261–274.
Tracy, P.B. and Mann, K.G. 1986. Platelet involvement in coagulation. In: Holmsen, H., ed., Platelet responses and metabolism. Vol. I. Boca Raton: CRC Press, 297–324.
Nemerson, Y. 1988. Tissue factor and hemostasis. Blood 71: 1–8.
Nurden, A.T., George, J.N. and Phillips, D.R. 1986. Platelet membrane glycoproteins: Their structure, function, and modification in disease. In: Phillips, D.R. and Shuman, M., eds., Biochemistry of platelets. 159–224.
Plow, E.F., Srouji, A.H., Meyer, D., Marguerie, G. and Ginsberg, M.H. 1984. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J. Biol. Chem. 259: 5388–5391.
Staatz, W.D., Rajpara, S.M., Wayner, E.A., Carter, W.G. and Santoro, S.A. 1989. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J. Cell Biol. 108: 1917–1924.
Coller, B.S., Beer, J.H., Scudder, L.E. and Steinberg, M.H. 1989. Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 74: 182–192.
Ruggeri, Z.M. and Zimmerman, T.S. 1987. von Willebrand factor and von Willebrand disease. Blood 70: 895–904.
Phillips, D.R. 1985. Receptors for platelet agonists. In: George, J.N., Nurden, A.T. and Phillips, D.R., eds., Platelet membrane glycoproteins. New York: Plenum Press, 145–169.
Asch, A.S., Barnwell, J., Silverstein, R.L. and Nachman, R.L. 1987. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 79: 1054–1061.
McGregor, J.L., Catimel, B., Parmentier, S., Clezardin, P., Dechavanne, M., Leung, L.L.K. 1989. Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J. Biol. Chem. 264: 501–506.
Silverstein, R.L., Leung, L.L.K. and Nachman, R.L. 1987. Thrombospondin: A versatile multifunctional glycoprotein. Arteriosclerosis 6: 245–253.
Cazenave, J.-P., Blondowska, D., Richardson, M., Kinlough-Rathbone, R.L., Packham, M.A. and Mustard, J.F. 1979. Quantitative radioisotopic measurement and scanning electron microscopic study of platelet adherence to a collagen-coated surface and to subendothelium with a rotating probe device. J. Lab. Clin. Med. 93: 60–70.
Hanson, S.R., Harker, L.A. 1985. Studies of suloctidil in experimental thrombosis in baboons. Thromb. Haemost. 53: 423–427.
Badimon, L., Badimon, J.J., Turitto, V.T., Rand, J. and Fuster, V. 1989. Functional behaviour of vessels from pigs with von Willebrand disease. Values of platelet deposition are identical to those obtained on normal vessels. Arteriosclerosis 9: 184–188.
Sakariassen, K.S., Nievelstein, P.F.E.M., Coller, B.S. and Sixma, J.J. 1986. The role of platelet membrane glycoproteins Ib and IIb-1í1a in platelet adherence to human artery subendothelium. Br. J. Haematol. 63: 681–691.
de Groot, P.G. and Sixma, J.J. 1987. Role of von Willebrand factor in the vessel wall. Semin. Thromb. Heurost. 13: 416–424.
Badimon, L., Badimon, J.J., Turitto, V.T. and Fuster, V. 1989. Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions. Blood 73: 961–967.
Levine, J.D., Harlan, J.M., Harker, L.A., Joseph, M.L. and Counts, R.B. 1982. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood 60: 531–534.
Ribes, J.A., Francis, C.W. and Wagner, D.D. 1987. Fibrin induces release of von Willebrand factor from endothelial cells. J. Clin. Invest. 79: 117–123.
Stel, H.V., Sakariassen, K.S., de Groot, P.O., van Mourik, J.A. and Sixma, J.J. 1985. von Willebrand factor in the vessel wall mediates platelet adherence. Blood 65: 85–90.
Bastida, E., Escolar, G., Ordinas, A. and Sixma, J.J. 1987. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood 70: 1437–1442.
Wayner, E.A., Carter, W.G., Piotrowicz, R.S. and Kunicki, T.J. 1988. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: Preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J. Cell Biol. 107: 1881–1891.
Houdijk, W.P.M. and Sixma, J.J. 1985. Fibronectin in artery subendothelium is important for platelet adhesion. Blood 65: 598–604.
Ginsberg, M., Pierschbacher, M.D., Ruoslahti, E., Marguerie, G., Plow, E. 1985. Inhibition of fibronectin binding to platelet by proteolytic fragments and synthetic peptides which support fibroblast adhesion. J. Biol. Chem. 260: 3931–3936.
Piotrowicz, R.S., Orchekowski, R.P., Nugent, D.J., Yamada, K.Y. and Kunicki, T.J. 1988. Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J. Cell Biol. 106: 1359–1364.
Nievelstein, P.F.E.M. and Sixma, J.J. 1988. Glycoprotein IIB-IIIA and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions. Blood 72: 82–88.
Turitto V.T., Weiss, H.J., Baumgartner, H.R. 1984. Platelet interaction with rabbit subendothelium in von Willebrand’s disease: Altered thrombus formation distinct from defective platelet adhesion. J. Clin. Invest. 74: 1730–1741.
Weiss, H.J., Hawiger, J., Ruggeri, Z.M., Turitto, V.T., Thiagarajan, P. and Hoffmann, T. 1989. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin. Invest. 83: 288–297.
Nieuwenhuis, H.K., Akkerman, J.W.N., Houdijk, W.P.M. and Sixma, J.J. 1985. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318: 470–472.
Kehrel, B., Balleisen, L., Kokott, R., et al. 1988. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 71: 1074–1078.
Knapp, W., Dörken B., Rieber, P., Schmidt, R.E., Stein, H. and von den Borne, A.E.G.K. 1989. CD antigens. Blood 74: 1448–1450.
Tandon, N.N., Kralisz, U. and Jamieson, G.A. 1989. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264: 7576–7583.
Nakano, T., Hanasaki, K. and Arita, H. 1989. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. J. Biol. Chem. 264: 5400–5406.
Groves, H.M., Kinlough-Rathbone, R.L., Richardson, M., Moore, S. and Mustard, J.F. 1979. Platelet interaction with damaged rabbit aorta. Lab. Invest. 40: 194–200.
O’Neill, W., Timmis, G.C., Bourdillon, P.D., et al. 1986. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. New Enal. J. Med. 314: 812–818.
Ellis, S.G., Roubin, G.S., King, S.B. III, Douglas, J.S. Jr. and Cox, W.R. 1989. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 63: 30–34.
Phillips, D.R., Charo, I.F., Parise, L.V. and Fitzgerald, L.A. 1988. The platelet membrane glycoprotein IIb-IIIa complex. Blood 71: 831–843.
Kunicki, T.J. 1989. Platelet membrane glycoproteins and their function: An overview. Blut 59: 30–34.
Hawiger, J. 1987. Formation and regulation of platelet and fibrin hemostatic plug. Hum. Pathol. 18: 111–122.
Mustard, J.F., Packham, M.A., Kinlough-Rathbone, R.L., Perry, D.W. and Regoeczi, E. 1978. Fibrinogen and ADP-induced platelet aggregation. Blood 52: 453–466.
Peerschke, E.I., Zucker, M.B., Grant, R.A., Egan, J.J., Johnson, M.M. 1990. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 55: 841–847.
Bennett, J.S. and Vilaire, G. 1979. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J. Clin. Invest. 64: 1393–1401.
Marguerie, G., Ginsberg, M. and Plow, E.F. 1987. Glycoproteins: The fibrinogen receptor. In: Holmsen, H., ed., Platelet responses and metabolism. Vol III. Response-metabolism relationships. Boca Raton: CRC Press, 285–296.
Mustard, J.F., Kinlough-Rathbone, R.L., Packham, M.A., Perry, D.W., Harfenist, E.J. and Pai, K.R.M. 1979. Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. Blood 54: 987–993.
Plow, E.F., Pierschbacher, M.D., Ruoslahti, E., Marguerie, G. and Ginsberg, M.H. 1987. Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. Blood 70: 110–115.
Andrieux, A., Hudry-Clergeon, G., Ryckewaert, J.-J., et al. 1989. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa. J. Biol. Chem. 264: 9258–9265.
D’Souza, S.E., Ginsberg, M.H., Burke, T.A., Lam, S.C.-T. and Plow, E.F. 1988. Local-ization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 242: 91–93.
D’Souza, S.E., Ginsberg, M.H. and Plow, E.F. 1990. A discrete region of the platelet integrin, GPIIb-IIIa involved in ligand recognition. FASEB J. 4: A892.
Harfenist, E.J., Packham, M.A., Kinlough-Rathbone, R.L., Cattaneo, M. and Mustard, J.F. 1987. Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. Blood 70: 827–831.
Suzuki, H., Kinlough-Rathbone, R.L., Packham, M.A., Tanoue, K., Yamazaki, H. and Mustard, J.F. 1988. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphateinduced responses and enhanced fibrinogen binding in a medium with low calcium levels. Blood 71: 850–860.
Legrand, C., Dubernard, V. and Nurden, A.T. 1989. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Blood 73: 1226–1234.
Courtois, G., Ryckewaert, J.-J., Woods, V.L., Ginsberg, M.H., Plow, E.F. and Marguerie, G.A. 1986. Expression of intracellular fibrinogen on the surface of stimulated platelets. Eur. J. Biochem. 159: 61–67.
Suzuki, H., Kinlough-Rathbone, R.L., Packham, M.A., Tanoue, K., Yamazaki, H. and Mustard, J.F. 1988. Immunocytochemical localization of fibrinogen during thrombin-induced aggregation of washed human platelets. Blood 71: 1310–1320.
Fujimoto, T. and Hawiger, J. 1982. Adenosine diphosphate induces binding of von Willebrand factor to human platelets. Nature 297: 154–156.
De Marco, L., Girolami, A., Zimmerman, T.S. and Ruggeri, Z.M. 1986. von Wille-brand factor interaction with the glycoprotein IIb/IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J. Clin. Invest. 77: 1272–1277.
Pietu, G., Cherel, G., Marguerie, G. and Meyer, D. 1984. Inhibition of von Willebrand factor-platelet interaction by fibrinogen. Nature 308: 648–649.
Gralnick, H.R., Williams, S.B. and Coller, B.S. 1984. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Blood 64: 797–800.
Schullek, J., Jordan, J. and Montgomery, R.R. 1984. Interaction of von Willebrand factor with human platelets in the plasma milieu. J. Clin. Invest. 73: 421–428.
Gartner, T.K. and Bennett, J.S. 1985. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol. Chem. 260: 11891–11894.
Haverstick, D.M., Cowan, J.F., Yamada, K.M. and Santoro, S.A. 1985. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin. Blood 66: 946–952.
Plow, E.F., Pierschbacher, M.D., Ruoslahti, E., Marguerie, G.A. and Ginsberg, M.H. 1985. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. USA 82: 8057–8061.
Cook, J.J., Huang, T.-F., Rucinski, B., et al. 1989. Inhibition of platelet hemostatic plug formation bytrigramin, a novel RGD-peptide. Am. J. Physiol. 256: Hl038-H1043.
Kloczewiak, M., Timmons, S., Bednarek, M.A., Sakon, M. and Hawiger, J. 1989. Platelet receptor recognition domain on the c chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 28: 2915–2919.
Coller, B.S., Folts, J.D., Smith, S.R., Scudder, L.E. and Jordan, R. 1989. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation 80: 1766–1774.
Mickelson, J.K., Simpson, P.J., Cronin, M., et al. 1990. Antiplatelet antibody [7E3 F(ab’)2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model. Circulation 81: 617–627.
Coller, B.S., Scudder, L.E., Berger, H.J. and Iuliucci, J.D. 1988. Inhibition of human platelet function in vivo with a monoclonal antibody with observations on the newly dead as experimental subjects. Ann. Intern. Med. 109: 635–638.
Cattaneo, M., Kinlough-Rathbone, R.L., Lecchi, A., Bevilacqua, C., Packham, M.A. and Mustard, J.F. 1987. Fibrinogen-independent aggregation and deaggregation of human platelets: Studies in two afibrinogenemic patients. Blood 70: 221–226.
De Marco, L., Girolami, A., Zimmerman, T.S. and Ruggeri, Z.M. 1986. von Willebrand factor interaction with the glycoprotein IIb/IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J. Clin. Invest. 77: 1272–1277.
Soria, J., Soria, C., Borg, J.Y., et al. 1985. Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology. Br. J. Haematol. 60: 503–514.
Bauman, J.E., Reimers, H.J. and Joist, J.H. 1987. Deaggregation of in vitro degranulated human platelets: Irreversibility of aggregation may be agonist-specific rather than related to secretion per se. Thromb. Haemost. 58: 899–904.
Kinlough-Rathbone, R.L., Packham, M.A., Cattaneo, M. and Mustard, J.F. 1990. Studies with thrombin-degranulated human platelets: Conditions influencing their responsiveness and the stability of aggregates. (in preparation)
Stenberg, P.E., McEver, R.P., Shuman, M.A., Jacques, Y.V. and Bainton, D.F. 1985. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell Biol. 101: 880–886.
Berman, C.L., Yeo, E.L., Wencel-Drake, J.D., Furie, B.C., Ginsberg, M.H. and Furie, B. 1986. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J. Clin. Invest. 78: 130–137.
Hattori, R., Hamilton, K.K., Fugate, R.D., McEver, R.P. and Sims, P.J. 1989. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J. Biol. Chem. 264: 7768–7771.
Ronfanti, R., Furie, B.C., Furie, B. and Wagner, D.D. 1989. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 73: 1109–1112.
George, J.N., Pickett, E.B., Saucerman, S., et al. 1986. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J. Clin. Invest. 78:340–348.
Palabrica, T.M., Furie, B.C., Konstam, M.A., et al. 1989. Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets. Proc. Natl. Acad. Sci. USA 86: 1036–1040.
Johnston, G.I., Pickett, E.B., McEver, R.P. and George, J.N. 1987. Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood 69: 1401–1403.
Metzelaar, M.J., Sixma, J.J. and Nieuwenhuis, H.K. 1989. Detection of activated platelets with monoclonal antibodies (abstr). Thromb. Haemost. 62: 164.
Zimmerman, G.A., McIntyre, T.M., Prescott, S.M. and McEver, R.P. 1989. Granule membrane protein 140 (GMP-140) mediates neutrophil adhesion to activated human endothelium. Blood 74 (suppl 1): 46a.
Hamburger, S.A. and McEver, R.P. 1990. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 75: 550–554.
Larsen, E., Celi, A., Gilbert, G.E., et al. 1989. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59: 305–312.
Bevilacqua, M.P., Stengelin, S., Gimbrone, M.A. Jr. and Seed, B. 1989. Endothelial leukocyte adhesion molecule I: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243: 1160–1165.
Jamieson, G.A. and Okumura, T. 1978. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J. Clin. Invest. 61: 861–864.
Phillips, D.R. and Agin, P.P. 1977. Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. Biochem. Biophvs. Res. Commun. 75: 940–947.
Workman, E.F. Jr., White, G.C. II and Lundblad, R.L. 1977. Structure-function relationships in the interaction of a-thrombin with blood platelets. J. Biol. Chem. 252: 7118–7123.
Hallam, T.J. and Rink, T.J. 1989. Receptor-mediated ?a2+ entry: Diversity of function and mechanism. TIPS 10: 8–10.
Jones, G.D. and Gear, A.R.L. 1988. Subsecond calcium dynamics in ADP- and thrombin-stimulated platelets: A continuous-flow approach using indo-1. Blood 71: 1539–1543.
Gerrard, J.M., McNicol, A., Klassen, D., Israels, S.J. 1989. Protein phosphorylation and its relation to platelet function. In: Meyer, P. and Marche, P., eds. Blood cells and arteries in hypertension and atherosclerosis. New York: Raven Press, 93–114.
Packham, M.A., Kinlough-Rathbone, R.L., Reimers, H.-J., Scott, S., Mustard, J.F. 1977. Mechanisms of platelet aggregation independent of adenosine diphosphate. In: Silver, M.J., Smith, J.B. and Koksis, J.J., eds. Prostaglandins in hematology. New York: Spectrum Publications, 247–276.
Packham, M.A., Bryant, N.L., Guccione, M.A., Kinlough-Rathbone, R.L. and Mustard, J.F. 1989. Effect of the concentration of Сa2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Thromb. Haemost. 62: 968–976.
Fisher, G.J., Bakshian, S. and Baldassare, J.J. 1985. Activation of human platelets by ADP causes a rapid rise in cytosolic free calcium without hydrolysis of phosphatidylinositol-4, 5-bisphosphate. Biochem. Biophvs. Res. Commun. 129: 958–964.
Vickers, J.D., Kinlough-Rathbone, R.L., Packham, M.A. and Mustard, J.F. 1990. Inositol phospholipid metabolism in human platelets stimulated by ADP. Eur. J. Biochem. (in press).
Sage, S.O. and Rink, T.J. 1987. The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. J. Biol. Chem. 262: 16364–16369.
Kinlough-Rathbone, R.L., Cazenave, J.-P., Packham, M.A. and Mustard, J.F. 1980. Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. Lab. Invest. 42: 28–34.
Murray, R. and FitzGerald, G.A. 1989. Regulation of thromboxane receptor activation in human platelets. Proc. Natl. Acad. Sci. USA 86: 124–128.
Lalau Keraly, C., Kinlough-Rathbone, R.L., Packham. M.A., Suzuki, H. and Mustard, J.F. 1988. Conditions affecting the responses of human platelets to epinephrine. Thromb. Haemost. 60: 209–216.
Lanza, F., Beretz, A., Stierle, A., Hanau, D., Kubina, M. and Cazenave, J.-P. 1988. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am. J. Phvsiol. 255: H1276–H1288.
Kinlough-Rathbone, R.L. and Mustard, J.F. 1986. Synergism of agonists. In: Holmsen, H., ed. Platelet responses and metabolism. Vol. I. Responses. Boca Raton: CRC Press, 193–207.
Kinlough-Rathbone, R.L., Mustard, J.F., Perry, D.W., et al. 1983. Factors influencing the deaggregation of human and rabbit platelets. Thromb. Haemost. 49: 162–167.
Kinlough-Rathbone, R.L., Perry, D.W., Packham, M.A. and Mustard, J.F. 1985. Deaggregation of human platelets aggregated by thrombin. Thromb. Haemost. 53: 42–44.
Cattaneo, M., Canciani, M.T., Lecchi, A., et al. 1990. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 75: 1081–1086.
Vaughan, D.E., Plavin, S.R., Schafer, A.I. and Loscalzo, J. 1989. PGE1 accelerates thrombolysis by tissue plasminogen activator. Blood 73: 1213–1217.
Lam, S.C.-T., Dieter, J.P., Strebel, L.C., Muscolino, G., Feinberg, H. and Le Breton, G.C. 1989. Rapid dissociation of platelet-fibrin clots in vitro by a combination of fibrinolytic and antiplatelet agents. Blood 74 (suppl 1): 295a.
Coller, B.S. 1990. Platelets and thrombolytic therapy. New Engl. J. Med. 322: 33–42.
Schafer, A.I., Maas, A.K., Ware, J.A., Johnson, P.C., Rittenhouse, S.E. and Salzman, E.W. 1986. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J. Clin. Invest. 78: 73–79.
Shebuski, R.J., Bloom, J.C., Sellers, T.S., et al. 1989. Attenuation of the inhibitory effect of prostacyclin on platelet function after tissue plasminogen activator or streptokinase infusion in the rabbit. Fibrinolvsis 3: 115–123.
Fitzgerald, D.J. 1989. Platelet inhibition with an antibody to glycoprotein IIb/IIIa. Circulation 80: 1918–1919.
Verstraete, M. 1989. Thrombolysis: An approach still on the move. Drugs 37: 116–122.
Schumacher, W.A. and Heran, C.L. 1989. Effect of thromboxane antagonism on recanalization during streptokinase-induced thrombolysis in anesthetized monkeys. J. Cardiovasc. Pharmacol. 13: 853–861.
Golino, P., Ashton, J.H., McNatt, J., et al. 1989. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis. Circulation 79: 911–919.
Terres, W., Beythien, C., Kupper, W. and Bleifeld, W. 1989. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis. Circulation 79: 1309–1314.
Lewis, H.D. Jr., Davis, J.W., Archibald, D.G., et al. 1983. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. New Engl. J. Med. 309: 396–403.
Cairns, J.A., Gent, M., Singer, J., et al. 1985. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. New Engl. J. Med. 313: 1369–1375.
Eidt, J.F., Allison, P., Noble, S., et al. 1989. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J. Clin. Invest. 84: 18–27.
Heras, M., Chesebro, J.H., Penny, W.J., Bailey, K.R., Badimon, L. and Fuster, V. 1989. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 79: 657–665.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Packham, M.A. (1991). Platelet Reactions in Thrombosis. In: Gotlieb, A.I., Langille, B.L., Fedoroff, S. (eds) Atherosclerosis. Altschul Symposia Series, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3754-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3754-0_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6672-0
Online ISBN: 978-1-4615-3754-0
eBook Packages: Springer Book Archive